Crossmark

Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s12933-019-0875-4

Published Online: 2019-06-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seidu, Samuel http://orcid.org/0000-0002-8335-7018
Kunutsor, Setor K.

Sesso, Howard D.

Gaziano, J. M.

Buring, J. E.

Roncaglioni, Maria Carla

Khunti, Kamlesh
Funding

Funding for this research was provided by:

Collaboration for Leadership in Applied Health Research and Care - East Midlands
License Information

Text and Data Mining valid from 2019-06-03

Version of Record valid from 2019-06-03
More Information

Article History

Received: 20 April 2019

Accepted: 25 May 2019

First Online: 3 June 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below